Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 14, 2025
Cerebrospinal fluid proteomic associations of APOE genotypes reveal distinct protective and risk mechanisms for Alzheimer's diseaseEleonora M Vromen, Senne B Lageman, Johan Gobom, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 12, 2019
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrumIsabelle Bos, Stephanie Vos, Frans Verhey, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 12, 2025
Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapiesSara Rubio-Guerra, Isabel Sala, María Belén Sánchez-Saudinós, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 12, 2025
Development of amyloid-negative neuropsychological norms using GAMLSSSara Rubio-Guerra, María Belén Sánchez-Saudinós, Isabel Sala, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 29, 2017
Cortical microstructural changes along the Alzheimer's disease continuumVictor Montal, Eduard Vilaplana, Daniel Alcolea, et al.
Molecular Psychiatry|February 17, 2022
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammationAlexander Neumann, Fahri Küçükali, Isabelle Bos, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2025
Decreased practice effects in cognitively unimpaired amyloid betapositive individuals: a multicenter, longitudinal, cohort studyAdrià Tort-Merino, Agnès Pérez-Millan, Neus Falgàs, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 5, 2022
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traitsFahri Küçükali, Alexander Neumann, Jasper Van Dongen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2021
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levelsShengjun Hong, Valerija Dobricic, Olena Ohlei, et al.
Frontiers in Aging Neuroscience|April 7, 2022
Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery DatasetJan Homann, Tim Osburg, Olena Ohlei, et al.
Pageof 6